SCHEMBL1970693

SCHEMBL1970693

COc1nc(N)cnc1NS(=O)(=O)c1cccc(Cl)c1F

nearest known ligand 0.80

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CCR4 P51679 19/20 0.80
EDNRA P25101 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1968579 0.89 CCR4 (0.83) CCR4EDNRA
SCHEMBL1733142 0.89 CCR4 (1.00) CCR4EDNRA
SCHEMBL1972204 0.89 CCR4 (0.79) CCR4
SCHEMBL1968930 0.83 CCR4 (0.74) CCR4EDNRA
SCHEMBL1967100 0.82 CCR4 (0.77) CCR4
SCHEMBL29369811 0.80 CCR4 (1.00) CCR4
SCHEMBL1966740 0.80 CCR4 (1.00) CCR4
SCHEMBL1972347 0.79 CCR4 (0.81) CCR4EDNRA
SCHEMBL1732702 0.77 CCR4 (0.74) CCR4
SCHEMBL1732492 0.77 CCR4 (1.00) CCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101370793-B N- (fluoro-pyrazinyl) -benzenesulfonamides as modulators of chemokine receptor CCR4 ASTRAZENECA AB 2012-01-04 CN disclosed
EP-1968951-B1 NOVEL N-(FLUORO-PYRAZINYL)-PHENYLSULFONAMID.ES AS MOODULATORS OF CHEMOKINE RECEPTOR CCR4. ASTRAZENECA AB (SE) 2011-06-22 EP disclosed
US-20100144759-A1 NOVEL N-(FLUORO-PYRAZINYL)-PHENYLSULFONAMIDES AS MODULATORS OF CHEMOKINE RECEPTOR CCR4 ASTRAZENECA AB (SE) 2010-06-10 US disclosed
US-20100144759-A1 NOVEL N-(FLUORO-PYRAZINYL)-PHENYLSULFONAMIDES AS MODULATORS OF CHEMOKINE RECEPTOR CCR4 ASTRAZENECA AB (SE) 2010-06-10 US disclosed
US-20100144759-A1 NOVEL N-(FLUORO-PYRAZINYL)-PHENYLSULFONAMIDES AS MODULATORS OF CHEMOKINE RECEPTOR CCR4 ASTRAZENECA AB (SE) 2010-06-10 US disclosed
CN-101370793-A Novel N- (fluoro-pyrazinyl) -benzenesulfonamides as modulators of chemokine receptor CCR4 ASTRAZENECA AB (SE) 2009-02-18 CN disclosed
US-20080293742-A1 Novel N-(Fluoro-Pyrazinyl)-Phenylsulfonamides as Modulators of Chemokine Receptor Ccr4 ASTRAZENECA AB (SE) 2008-11-27 US disclosed
US-20080293742-A1 Novel N-(Fluoro-Pyrazinyl)-Phenylsulfonamides as Modulators of Chemokine Receptor Ccr4 ASTRAZENECA AB (SE) 2008-11-27 US disclosed
US-20080293742-A1 Novel N-(Fluoro-Pyrazinyl)-Phenylsulfonamides as Modulators of Chemokine Receptor Ccr4 ASTRAZENECA AB (SE) 2008-11-27 US disclosed
EP-1968951-A1 NOVEL N-(FLUORO-PYRAZINYL)-PHENYLSULFONAMID.ES AS MOODULATORS OF CHEMOKINE RECEPTOR CCR4. AstraZeneca AB (SE) 2008-09-17 EP disclosed
WO-2007069978-A1 NOVEL N-(FLUORO-PYRAZINYL)-PHENYLSULFONAMID.ES AS MOODULATORS OF CHEMOKINE RECEPTOR CCR4. ASTRAZENECA AB (SE) 2007-06-21 WO disclosed
WO-2007069978-A1 NOVEL N-(FLUORO-PYRAZINYL)-PHENYLSULFONAMID.ES AS MOODULATORS OF CHEMOKINE RECEPTOR CCR4. ASTRAZENECA AB (SE) 2007-06-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293742-A1 Novel N-(Fluoro-Pyrazinyl)-Phenylsulfonamides as Modulators of Chemokine Receptor Ccr4 CCR4, CCR1, CCR3 CCR4 1/4885EDNRA 74/4885
US-20100144759-A1 NOVEL N-(FLUORO-PYRAZINYL)-PHENYLSULFONAMIDES AS MODULATORS OF CHEMOKINE RECEPTOR CCR4 CCR4, CCR1, CCR3 CCR4 1/4885EDNRA 74/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.